Decoding Secukinumab Injection: A New Precision Treatment Option...

adicionou um novo artigo Health

2026-01-27 09:31:46 - Traduzir -

Decoding Secukinumab Injection: A New Precision Treatment Option for Immune Inflammatory Diseases

In the field of immune-mediated inflammatory disease (IMID) treatment, the advent of biologic therapies has broken the limitations of traditional approaches and brought renewed hope for recovery to countless patients. As the world’s first fully human monoclonal antibody targeting interleukin-17A (IL-17A) to receive regulatory approval, secukinumab (Cosentyx) injection has...

0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior